12 March 2008
Immtech Announces Update On Business Operations

22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine

19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008

13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor

11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results

06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008

28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM

26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold

05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

往新闻稿网页

从Adobe网站下载免费拷贝

董事会成员

Eric L. Sorkin
管理队伍

• Mr. Sorkin has been affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a director for the Company, and more recently was appointed Chairman of the Board and CEO. Mr. Sorkin began his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary of Morgan Stanley, and from an entry-level position, he was promoted to Managing Director within six years. He was among the core group of professionals at the firm, which developed the firm?s investment portfolio with assets of over USD $3 billion. Corporations, banks and entities with which Mr. Sorkin worked on completed transactions included Aetna, International Paper, Continental Insurance, Barclays Banks, Chase Manhattan, Harvard University, Southern Bell, Cigna, the State of Wisconsin, AIG, Modern Woodman of America, Zurich American Life, and San Francisco City and County. Mr. Sorkin was responsible for investment selection, negotiations, transaction and financial structuring, debt placement, and asset management. Mr. Sorkin was Vice President, Owner, and/or Director of over 20 public investment partnerships with investment funds totaling over USD $1 billion. In 1993, Mr. Sorkin created his own investment firm and began making private equity investments in the U.S. and in China. Mr. Sorkin graduated Yale University with a B.A. in Economics.

Cecilia Chan
副主席

David Fleet
David Fleet Pharmaceutical Industry Consultancy Services 董事长
OnMedica Group Ltd. 非执行总监
IatRx Pharma 总监

Judy Lau
Convergent Business Group 主席
中国香港

Levi Hong Kaye Lee, M.D.
玛丽医院
中国香港

Donald F. Sinex
董事会董事
Devonwood, Inc.

Advisors

Dr. Dorothy S. Zinberg
Center for Science and International Affairs
Kennedy School of Government
Harvard University

使用条件 | 私隐条例
? 2007 Immtech. 版权所有